Remove Government Remove Pharma Remove Pharmaceutical manufacturing
article thumbnail

Key developments in pharmaceutical manufacturing – September 2023

European Pharmaceutical Review

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Kerry, Ireland.

article thumbnail

Innovative pharma-government partnership to enhance UK clinical trials

European Pharmaceutical Review

Sustainable pharmaceutical manufacturing innovation: around 20 percent of the funding will be directed towards initiatives focused on environmentally friendly manufacturing in the industry. The post Innovative pharma-government partnership to enhance UK clinical trials appeared first on European Pharmaceutical Review.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma responds to 2024 UK General Election

European Pharmaceutical Review

Following the Labour Party’s win yesterday in the UK 2024 General Election, industry representatives have voiced their opinions on what this could mean for the future of the pharmaceutical industry under the new government. EU pharmacovigilance is stronger with the UK, and UK research is stronger with the EU.”

Pharma 98
article thumbnail

As pharma abandons the antibiotic market patients are at risk

World of DTC Marketing

A pull strategy is needed with financial incentives to repair the broken market for antibiotics and make it worthwhile for the pharma industry to bring promising drugs to market. Pew Internet reminds us all that, above all, the pharma industry is a business. The pharma industry is warning of the consequences of inaction. “If

Marketing 174
article thumbnail

Common pharma compliance concerns cited by FDA warning letters

European Pharmaceutical Review

Warning letters issued by FDA can be an important source of data to study and analyse violations that occur in pharmaceutical manufacturing. The post Common pharma compliance concerns cited by FDA warning letters appeared first on European Pharmaceutical Review. What can we learn from contamination control failures?

FDA 105
article thumbnail

Invest now to reduce manufacturing harms to environment, says pharma survey

Pharmaceutical Technology

The pharmaceutical industry must improve its environmental footprint by investing in technology and expertise, as well as through better design of new drugs early in their development, according to a GlobalData survey of the pharmaceutical industry.

article thumbnail

Cleanrooms-on-demand: a more efficient future for pharma?

pharmaphorum

However, with cleanrooms-on-demand representing a feasible and accessible opportunity for those across pharmaceutical manufacturing, what are the key challenges in adoption and how can we expect the industry to overcome them to reap the rewards on offer? But with a single dedicated cleanroom environment costing around $2.5

Pharma 95